Lehman’s journal blog again highlights the unenviable choices in Oncoland. If he had non-small-cell lung cancer that recurred after first line treatment, he would prefer to “buy a case or two of malt whiskey, and book a good hotel in Venice”, rather than choosing between docetaxel or one of the newer treatments.
These are so good that I think they should be shared more widely. As they say on the TV, this is in no particular order.
Don Dizon’s blog this week for the American Society of Clinical Oncology was about how he had to / chose to break bad news to another doctor’s patient.
Life expectancy for patients with CHF is worse than for any of the common cancers. Despite the advances:
This week’s ‘What your patient is thinking’ in the BMJ describes what it was like when someone who had been ‘in care’, Aine Kelly, started to access healthcare again.
Oops! It’s actually called the Cancer Drugs Fund, isn’t it! And it was supposed to be a British government initiative, not a Conservative Party vote winner.
This week in the BMJ, the excellent David Oliver collated some distressing data about hospital admissions and nursing and care home residents: